Literature DB >> 17353909

Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition.

Y Tong1, Y Tan, C Zhou, S Melmed.   

Abstract

Pituitary tumor transforming gene (PTTG1) was isolated from rat pituitary tumor cells, and subsequently identified as a securin protein as well as a transcription factor. We show here a global transcriptional effect of PTTG1 in human choriocarcinoma JEG-3 cells by simultaneously assessing 20,000 gene promoters using chromatin immunoprecipitation (ChIP)-on-Chip experiments. Seven hundred and forty-six gene promoters (P<0.001) were found enriched, with functions relating to cell cycle, metabolic control and signal transduction. Significant interaction between PTTG1 and Sp1 (P<0.000001) was found by transcriptional pattern analysis of ChIP data and further confirmed by immunoprecipitation and pull-down assays. PTTG1 acts coordinately with Sp1 to induce cyclin D3 expression approximately threefold, and promotes G1/S-phase transition independently of p21. PTTG1 deletion was also protective for anchorage-independent cell colony formation. The results show that PTTG1 exhibits properties of a global transcription factor, and specifically modulates the G1/S-phase transition by interacting with Sp1. This novel signaling pathway may be required for PTTG1 transforming activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17353909      PMCID: PMC2736684          DOI: 10.1038/sj.onc.1210339

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  29 in total

1.  Genome-wide location and function of DNA binding proteins.

Authors:  B Ren; F Robert; J J Wyrick; O Aparicio; E G Jennings; I Simon; J Zeitlinger; J Schreiber; N Hannett; E Kanin; T L Volkert; C J Wilson; S P Bell; R A Young
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

2.  Expression of PTTG and prc1 genes during telencephalic neurogenesis.

Authors:  V Tarabykin; O Britanova; A Fradkov; A Voss; L S Katz; S Lukyanov; P Gruss
Journal:  Mech Dev       Date:  2000-04       Impact factor: 1.882

3.  Sp1 as G1 cell cycle phase specific transcription factor in epithelial cells.

Authors:  Edgar Grinstein; Franziska Jundt; Inge Weinert; Peter Wernet; Hans-Dieter Royer
Journal:  Oncogene       Date:  2002-02-28       Impact factor: 9.867

4.  Pituitary tumor transforming gene (PTTG) regulates placental JEG-3 cell division and survival: evidence from live cell imaging.

Authors:  R Yu; S G Ren; G A Horwitz; Z Wang; S Melmed
Journal:  Mol Endocrinol       Date:  2000-08

5.  Expression of pituitary-tumour transforming gene in colorectal tumours.

Authors:  A P Heaney; R Singson; C J McCabe; V Nelson; M Nakashima; S Melmed
Journal:  Lancet       Date:  2000-02-26       Impact factor: 79.321

6.  Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division.

Authors:  Z Wang; R Yu; S Melmed
Journal:  Mol Endocrinol       Date:  2001-11

7.  Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function.

Authors:  L Pei
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

8.  A novel binding factor facilitates nuclear translocation and transcriptional activation function of the pituitary tumor-transforming gene product.

Authors:  W Chien; L Pei
Journal:  J Biol Chem       Date:  2000-06-23       Impact factor: 5.157

9.  Identification of c-myc as a down-stream target for pituitary tumor-transforming gene.

Authors:  L Pei
Journal:  J Biol Chem       Date:  2000-12-13       Impact factor: 5.157

10.  Pituitary tumor transforming gene (PTTG) transforming and transactivation activity.

Authors:  Z Wang; S Melmed
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

View more
  36 in total

1.  Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteins.

Authors:  Sudhakar Chintharlapalli; Sabitha Papineni; Syng-Ook Lee; Ping Lei; Un Ho Jin; Steven I Sherman; Libero Santarpia; Stephen Safe
Journal:  Mol Carcinog       Date:  2011-01-25       Impact factor: 4.784

Review 2.  Genetics of SLE: evidence from mouse models.

Authors:  Laurence Morel
Journal:  Nat Rev Rheumatol       Date:  2010-05-04       Impact factor: 20.543

3.  Long noncoding RNA CCAT2 is activated by E2F1 and exerts oncogenic properties by interacting with PTTG1 in pituitary adenomas.

Authors:  Dongxia Fu; Yunna Zhang; Haibin Cui
Journal:  Am J Cancer Res       Date:  2018-02-01       Impact factor: 6.166

4.  RNF20 Suppresses Tumorigenesis by Inhibiting the SREBP1c-PTTG1 Axis in Kidney Cancer.

Authors:  Jae Ho Lee; Yong Geun Jeon; Kyoung-Hwa Lee; Hye Won Lee; Jeu Park; Hagoon Jang; Minyong Kang; Hye Sun Lee; Hee Jin Cho; Do-Hyun Nam; Cheol Kwak; Jae Bum Kim
Journal:  Mol Cell Biol       Date:  2017-10-27       Impact factor: 4.272

5.  Pttg1/securin is required for the branching morphogenesis of the mammary gland and suppresses mammary tumorigenesis.

Authors:  Rashieda J Hatcher; Jie Dong; Shuang Liu; Guangxing Bian; Alejandro Contreras; Tao Wang; Susan G Hilsenbeck; Yi Li; Pumin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-06       Impact factor: 11.205

6.  Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor.

Authors:  Ning-Ai Liu; Hong Jiang; Anat Ben-Shlomo; Kolja Wawrowsky; Xue-Mo Fan; Shuo Lin; Shlomo Melmed
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

7.  Sp1 transcription factor promotes TMEPAI gene expression and contributes to cell proliferation.

Authors:  Yuyin Li; Ailong Guo; Yajuan Feng; Yueying Zhang; Jianjun Wang; Lifang Jing; Yali Yan; Lei Jing; Zhenxing Liu; Long Ma; Aipo Diao
Journal:  Cell Prolif       Date:  2016-09-14       Impact factor: 6.831

8.  p21(Cip1) restrains pituitary tumor growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Kalman Kovacs; Anat Ben-Shlomo; Kolja Wawrowsky; Serguei Bannykh; Shlomo Melmed
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

9.  E2F1 induces pituitary tumor transforming gene (PTTG1) expression in human pituitary tumors.

Authors:  Cuiqi Zhou; Kolja Wawrowsky; Serguei Bannykh; Shiri Gutman; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2009-10-16

10.  PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target.

Authors:  Michael J Demeure; Kathryn E Coan; Clive S Grant; Richard A Komorowski; Elizabeth Stephan; Shripad Sinari; David Mount; Kimberly J Bussey
Journal:  Surgery       Date:  2013-12       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.